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THE PERSISTENCE AND SECONDARY POISONING RISKS OF SODIUM
MONOFLUOROACETATE (1080), BRODIFACOUM, AND CHOLECALCIFEROL IN
POSSUMS
C. T. EASON, G. R. WRIGHT, and L. MEIKLE, Manaaki Whenua - Landcare Research, P.O. Box 69, Lincoln,
New Zealand.
P. ELDER, Steroid and Immunobiochemistry Unit, Christchurch Health Laboratories, Christchurch Hospital, P.O. Box
151, Christchurch, New Zealand.
ABSTRACT: To determine the risk of secondary poisoning for animals preying on sub-lethally poisoned brushtail
possums, captive possums were treated with near-lethal doses of sodium monofluoroacetate (1080) or brodifacoum, and
toxicant concentrations in blood and tissue were monitored over time. Sodium monofluoroacetate was rapidly eliminated
from the blood (within three days). Brodifacoum was retained in the liver and, to a lesser extent, the muscle of possums
for eight months after dosing. To determine the potential risk for animals scavenging on the carcasses of possums
poisoned with cholecalciferol, cats were fed poisoned carcasses for six days. No changes in behavior, appetite, or body
weight were observed. Serum calcium concentrations increased slightly, but remained within the normal range for cats.
KEY WORDS: vertebrate pest control, secondary poisoning, sodium monofluoroacetate, brodifacoum, cholecalciferol
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INTRODUCTION
Sodium monofluoroacetate (1080) has been used for
vertebrate pest control in New Zealand since 1954. It is
currently used most frequently in aerially sown baits and
in baits in bait stations for the control of the Australian
brushtail possum (Jrichosurus vulpecula) (Livingstone
1994). The use of 1080 has been largely restricted to
authorized wildlife management staff within the
Department of Conservation and licensed operators within
regional councils. In recent years, community groups,
farmers and hunters have become more involved in
possum control, and alternatives to 1080 that can be used
without special permits have been sought. This need has
led to the registration of brodifacoum (Talon®) in 1991
and cholecalciferol (CAMPAIGN®) in 1995, and these two
poisons are now playing an increasingly significant role in
possum control.

1995), and toxic amounts of brodifacoum may be retained
in a carcass.
The existence of an effective antidote to brodifacoum
in the form of vitamin Kl means that dogs that have eaten
carcasses containing brodifacoum residues can usually be
saved. Unfortunately, there are no consistently effective
antidotes for 1080 poisoning.
In contrast, studies of dogs fed rats poisoned with
cholecalciferol suggest that the risk of secondary
poisoning with this pesticide is low (Marshall 1984).
However, these data may not be directly applicable to
possums, since higher concentrations of cholecalciferol
are used in possum baits (0.8%) compared with rat baits
(0.075%) which may lead to higher residue levels in the
possum carcasses.
In this paper persistence data is reported which may
be used to assess the magnitude and duration of the risks
of secondary poisoning of animals preying on live
possums which have been sub-lethally dosed with 1080 or
brodifacoum. In addition, preliminary tissue residue
results are reported in possums, and feeding study data
from cats fed possums that have been poisoned with
cholecalciferol.

An important consideration when using any vertebrate
pesticide is the risk of secondary poisoning. Secondary
poisoning can be in two forms: from non-target animals
scavenging poisoned possum carcasses, or from animals
preying on live possums that have the pesticide in their
tissues but have not received a lethal dose. Humans also
occasionally harvest possums for food.
Dogs are particularly susceptible to secondary
poisoning with 1080 (Eason et al. 1994a). Analyses of
1080 concentrations in rabbit carcasses have shown that
there is a substantial decrease in 1080 in muscle, liver,
and kidney during the first three weeks after death
(Gooneratne et al. 1994). However, recent analyses of
residue in possum carcasses after a control operation have
shown that 1080 can persist in tissues in amounts that
would be lethal to dogs for at least two to three months
(Meinken, pers. comm.), even though the carcasses had
substantially decomposed over this period. As for 1080,
the secondary poisoning risks from brodifacoumcontaminated carcasses are well known (Eason and Spurr

METHODS
Determining the Persistence of Sub-lethal Doses of
Brodifacoum and 1080
A stock solution of brodifacoum was obtained from
ICI Crop Care, Richmond, New Zealand and 1080
powder from Animal Control Products, Wanganui, New
Zealand. Groups of six possums (three male and three
female) were orally dosed with 0.1 mg/kg (2 ml/kg of a
0.05 mg/ml solution) of either brodifacoum in propylene
glycol or 1080 in distilled water. The animals were
allowed free access to food and water before dosing.
These doses were equivalent to a possum eating 10-20 g
of Talon® cereal baits containing 20 ppm brodifacoum,
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or approximately 0.5 g of cereal bait containing 1080
at 0.08%. Earlier studies have demonstrated that 100 to
200 g of Talon® bait or 5 to 10 g of 1080 bait would be
sufficient to kill most possums (Eason et al. 1994a). A
series of blood samples were taken from the jugular vein
of each possum before and after dosing. Samples were
taken at 0.5, 1, 1.5, 2, 3, 4, 8, 12, 24, 48, and 96 hr
after dosing with 1080, and at 4, 8, 24, and 48 hr and 7,
14, 21, 28, and 35 days after administration of
brodifacoum.
Previous studies in laboratory animals and sheep
demonstrated that concentrations of 1080 in blood exceed
those in tissue (Eason et al. 1994b). Thus, tissue samples
were not taken for 1080 analysis, since concentrations in
the blood provide a worst-case persistence profile. By
contrast, experiments in rats and sheep have shown that
higher concentrations of brodifacoum in tissues
(particularly the liver) exceed blood concentrations (Laas
et al. 1985). Hence, a further 32 possums were randomly
divided into groups of four animals each (two male and
two female). One group was killed before dosing and the
other seven groups at 2, 7, 14, 35, 64, 126 or 256 days
after dosing with brodifacoum at 0.1 mg/kg. Muscle
tissue and liver samples were collected at post-mortem.
All plasma and tissues were stored at -20°C for later
analysis. Brodifacoum was analyzed by high-performance
chromatography with fluorescence detection using
published methods of determining the compound in blood
(Kelice and Murphy 1989) and animal tissues (Hunter
1983). A gas-chromatography technique with electron
capture detection was used to measure the dichloroaniline
derivative of 1080 (Eason et al. 1994b).
The Persistence of Cholecalciferol in Possums
A stock solution of cholecalciferol was obtained from
AgrEvo, Pennants Hill, Sydney, Australia. Thirteen
possums were randomly divided into two groups and
orally dosed with 20 mg/kg (2 ml/kg of a 10 mg/ml
solution) of cholecalciferol diluted in corn oil. A dose of
20 mg/kg cholecalciferol would be equivalent to a possum
eating approximately 10 g of cereal bait containing
cholecalciferol (0.8%) which would be a lethal or nearlethal dose for most animals. Serial blood samples were
taken from three cholecalciferol-treated
animals
immediately before and at 3, 6, 9, 12, 17, 23, and 29
days after dosing. At 3 and 29 days after dosing, the
remaining ten possums were killed and samples of heart,
kidney, liver, abdominal fat, and femoral muscle tissues
were collected.
In order to gain biological activity, cholecalciferol
(Vitamin D3) must undergo metabolic conversion to 25hydroxy vitamin D (250HD), a major active metabolite
(Keiver et al. 1988). Concentrations of 250HD were
measured in possums after exposure to cholecalciferol as
an indication of vitamin D status. A radioimmunoassay
(Amersham International Ltd, Amesham, UK) based on
competition between unlabelled and tritium-labelled
250HD for binding to the 25-hydroxy vitamin D binding
protein from rickettic rat serum was used to determine
250HD concentrations. As with the 1080 and brodifacoum
experiment, all possums were allowed free access to food
and water before and after dosing, and plasma and tissue
samples were stored at -20°C before analysis.

Secondary Poisoning Feeding Studies
Twelve feral cats were exclusively fed whole
cholecalciferol-poisoned possum carcasses for five days.
Appetite and body weight were monitored daily, and
blood samples were taken for serum calcium
measurements at regular intervals.
RESULTS
Determining the Persistence of Sub-lethal Doses of
Brodifacoum and 1080
No differences were detected between the results from
male and female possums, so the data were combined.
Sodium monofluoroacetate was rapidly absorbed into the
blood and remained at peak concentrations (i.e., > 1
/tg/ml) for 0.5 to 8 hr after dosing. By 24 hr after
dosing, plasma concentrations had decreased to 0.025
/tg/ml. Trace amounts (0.006 /tg/ml) were detected at 48
hr after dosing. No 1080 could be detected in the blood
96 hr after dosing (Figure 1). By contrast, peak plasma
concentrations (i.e., > 1 /xg/ml) of brodifacoum occurred
in possums between 24 and 48 hr after dosing, and trace
amounts could still be detected in the blood of some
possums 21-28 days after dosing (Figure 2).
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Figure 1. Concentrations of 1080 (jug/ml ± SE) in possum
plasma after oral administration of 0.1 mg/kg.
Persistence of brodifacoum in the liver and muscle
differed markedly from persistence in the blood.
Measurable concentrations were found in the liver 254
days after dosing. Considerably lower concentrations
were also found in the muscle tissue (Table 1).
The Persistence of Cholecalciferol in Possums
Concentrations of 250HD in plasma increased from a
mean of 39.6 ng/ml before dosing to a mean of 949
ng/ml six days after exposure, and subsequently declined
to approximately 600 ng/ml by 29 days post-dosing
(Figure 3).
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Figure 2. Concentration of brodifacoum (/tg/ml ± SE) in
possum plasma after oral administration of 0.1 mg/kg.
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Figure 3. Concentrations (^g/ml ± SE) of 25-hydroxyvitamin
D (250HD) in possum plasma after oral administration of 20
mg/kg cholecalciferol.

Table 1. Mean brodifacoum concentrations in possum muscle, liver, and plasma after oral administration of
0.1 mg/kg to each group (n=4).
Time in days
after dosing

Concentration (^g/g or fig/ml + SE)
Liver

Muscle

Plasma

2

0.177(0.011)

0.016 (0.001)

0.118(0.021)

7

0.119(0.009)

0.011 (0.007)

0.034 (0.009)

14

0.100(0.032)

0.011 (0.000)

0.004 (0.003)

35

0.095 (0.023)

0.010 (0.002)

0.002 (0.002)

63

0.109(0.024)

0.008 (0.001)

0.000 (0.00)

126

0.075 (0.029)

0.009 (0.002)

0.000 (0.00)

254

0.085 (0.009)

0.007 (0.002)

0.000 (0.00)

Concentrations of 250HD in heart, kidney, liver, and
fat ranged from 40 to 60 ng/g 3 days after dosing, and
appeared to decrease in all tissues with the exception of
fat during the following 4-week period (Figure 4). As
with the 1080 and brodifacoum studies, sample size was
not adequate to detect any sex difference so the data from
both sexes were combined.

declined to baseline levels by 12 days post-dosing (Table
2). Appetite and body weight of the cats were not
affected (Figure 5).
DISCUSSION
After oral administration of sub-lethal amounts of
1080 to possums, 1080 was rapidly absorbed and
subsequently eliminated from the plasma. These results
in possums are consistent with our early results in
livestock (Eason et al. 1994b) and rabbits (Gooneratne
et al. 1995), and studies in mice which show rapid
elimination of 1080 (Sykes et al. 1987).
For livestock suspected of near or sub-lethal exposure
to 1080, it has been suggested that an adequate margin of
safety (for avoiding residues in food) would be achieved

Secondary Poisoning Feeding Studies
Each of the 12 cats ate approximately 1 kg of possum
carcasses containing residues of cholecalciferol over the
five-day period. At the end of five days mean serum
calcium concentrations were slightly elevated compared to
pre-treatment levels, but remained close to the normal
range for cats (2.0-2.7 mmol/L). Calcium concentrations
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Figure 4. Concentrations (jtg/ml ± SE) of 25-hydroxyvitamin
D (250HD) in possum tissue 3 (n=7) and 29 days (n=3) after
oral administration of 20 mg/kg cholecalciferol.

Figure 5. Mean bodyweight (kg ± SD) in cats before, during,
and after feeding on the carcasses of cholecalciferol-poisoned
possums.

Table 2. Mean serum Ca ++ (+ SE) concentrations in cats.
Pre-treatment

After 5 Days

1 Week Later

7 Weeks Later

2.54 (0.06)

2.75(0.10)

2.72 (0.07)

2.64 (0.03)

by imposing a minimum withholding period of five days.
Should a death in a flock or herd be attributed to 1080,
the withholding period should be doubled to ten days for
the surviving stock and the livestock removed to a 1080free pasture (Rammell 1993). The results would indicate
that a similar safety margin of at least ten days after baits
have been removed or decomposed would be appropriate
for possum to ensure that residues are not present in meat
harvested for human consumption. It is apparent that
there is a contrast between the persistence in living
animals which have received a sub-lethal dose of 1080
versus the persistence of 1080 in carcasses.
This is not the case with brodifacoum, where
persistence in possums is probable in both lethally and
sub-lethally poisoned animals.
This remarkable
persistence highlights the potential secondary and tertiary
risks associated with brodifacoum when used for possum
control. For example, feral pigs will scavenge possum
carcasses and it is apparent from this study that possums
dying up to eight months or more after being exposed to
brodifacoum may contain residues that could be
transferred to pigs. As feral pigs are hunted as a food
source in New Zealand, there is at least a theoretical risk
of tertiary poisoning of humans long after the use of
brodifacoum has been discontinued in a particular area.
A sensible precaution would be to recommend that the
livers from all game be discarded, since much higher
concentrations occur in the liver than in muscle or blood.
Even if residues in most animals never reached levels

capable of causing serious harm to meat-eaters, the
presence of brodifacoum in any meat could be a concern
to the public. The presence of brodifacoum in possum
carcasses is also likely to pose a hazard to predators such
as harrier hawks, as well as farm dogs.
The preliminary results with cholecalciferol indicated
that elevated concentrations of 250HD were present in
possum carcasses, and that they were likely to persist for
several weeks in animals that had received sub-lethal
doses. In comparison to other examples in the literature,
the clearance of elevated 250HD in poisoned possums
appeared to be quite slow. This is perhaps not surprising
since it has been shown in other animals that clearance of
250HD is dose dependent (Keiver et al. 1988), and
possums in the present study received extremely high
near-lethal doses. For example, the plasma elimination
half lives of 250HD were 15 to 36 days in humans when
vitamin D status was normal, but increased to 25 to 68
days in humans and cows experiencing vitamin D
toxicosis (Keiver et al. 1988).
The feeding study of cats appeared to confirm earlier
work with dogs (Marshall 1984) which indicated that the
risk of secondary poisoning with cholecalciferol is low.
This is despite the presence of elevated concentrations of
250HD in possum carcasses. Research in rats has
demonstrated that 250HD is active when administered
orally (Rambeck et al. 1990), but is partially degraded in
the intestinal tract (Frolick and Deluca 1971). Hence,
some degradation of 250HD in possum meat by cats
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during digestion probably protects them. Further studies
are planned with dogs to confirm the findings with cats,
since it is believed that the data suggests a low risk, but
not no risk, of secondary poisoning.
Even in the absence of this additional data, it is
apparent that the risks of secondary poisoning with
cholecalciferol are low when compared with brodifacoum
or 1080. Dogs and cats only need to eat a very small
portion of a possum carcass poisoned with 1080 to receive
a lethal dose, and pets or farm dogs could not feed
exclusively on possum carcasses containing 1080 for
brodifacoum for 5 days without becoming ill or dying.
Nevertheless, all pets and farm dogs should be
discouraged from eating animals that have been poisoned
with cholecalciferol, even if the risk of secondary
poisoning is perceived to be low, based on currently
available evidence.
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